Long-term Outcome of Diffuse Proliferative Lupus Glomerulonephritis Treated with Cyclophosphamide
- 30 April 2006
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 119 (4), 355.e25-355.e33
- https://doi.org/10.1016/j.amjmed.2005.08.045
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisAnnals Of The Rheumatic Diseases, 2004
- Treatment of severe proliferative lupus nephritis: the current stateAnnals Of The Rheumatic Diseases, 2003
- Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimensAmerican Journal of Kidney Diseases, 2001
- Factors predictive of outcome in severe lupus nephritisAmerican Journal of Kidney Diseases, 2000
- Clinical and prognostic value of serial renal biopsies in lupus nephritisAmerican Journal of Kidney Diseases, 1999
- Lupus nephritis in southern Chinese patients: Clinicopathologic findings and long-term outcomeAmerican Journal of Kidney Diseases, 1999
- Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black AmericansKidney International, 1997
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982